These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20693273

  • 1. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Nov; 69(11):1913-9. PubMed ID: 20693273
    [Abstract] [Full Text] [Related]

  • 2. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
    Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
    [Abstract] [Full Text] [Related]

  • 3. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Guillevin L, Holland M, Kirwan JR, Rovensky J, Saag KG, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
    [Abstract] [Full Text] [Related]

  • 4. Toward safer treatment with glucocorticoids: via patient and rheumatologist perspectives to recommendations on monitoring for adverse events.
    van der Goes MC, Jacobs JW, Bijlsma JW.
    Clin Exp Rheumatol; 2011 Jun; 29(5 Suppl 68):S116-20. PubMed ID: 22018196
    [Abstract] [Full Text] [Related]

  • 5. The safety of low-dose glucocorticoids in rheumatic diseases: results from observational studies.
    Hwang YG, Saag K.
    Neuroimmunomodulation; 2015 Jun; 22(1-2):72-82. PubMed ID: 25228230
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
    Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V, Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M, Schachna L, Sieper J, Boumpas DT, Dougados M.
    Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
    [Abstract] [Full Text] [Related]

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 8. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
    Avouac J, Kowal-Bielecka O, Landewe R, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Coauthors.
    Ann Rheum Dis; 2009 May; 68(5):629-34. PubMed ID: 18957486
    [Abstract] [Full Text] [Related]

  • 9. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW.
    Ann Rheum Dis; 2007 Dec; 66(12):1560-7. PubMed ID: 17660219
    [Abstract] [Full Text] [Related]

  • 10. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.
    Stelfox HT, Ahmed SB, Fiskio J, Bates DW.
    Clin Pharmacol Ther; 2004 Jan; 75(1):110-22. PubMed ID: 14749697
    [Abstract] [Full Text] [Related]

  • 11. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 12. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program.
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [Abstract] [Full Text] [Related]

  • 13. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma.
    Covar RA, Leung DY, McCormick D, Steelman J, Zeitler P, Spahn JD.
    J Allergy Clin Immunol; 2000 Oct; 106(4):651-9. PubMed ID: 11031335
    [Abstract] [Full Text] [Related]

  • 14. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [Abstract] [Full Text] [Related]

  • 15. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 16. Adverse events of intravenous glucocorticoid pulse therapy in inflammatory diseases: a meta-analysis.
    Smits NA, Duru N, Bijlsma JW, Jacobs JW.
    Clin Exp Rheumatol; 2011 Aug 04; 29(5 Suppl 68):S85-92. PubMed ID: 22018191
    [Abstract] [Full Text] [Related]

  • 17. The safety of low-dose glucocorticoids in rheumatic diseases.
    Hwang YG, Saag K.
    Clin Exp Rheumatol; 2011 Aug 04; 29(5 Suppl 68):S104-12. PubMed ID: 22018194
    [Abstract] [Full Text] [Related]

  • 18. Population-based assessment of adverse events associated with long-term glucocorticoid use.
    Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG.
    Arthritis Rheum; 2006 Jun 15; 55(3):420-6. PubMed ID: 16739208
    [Abstract] [Full Text] [Related]

  • 19. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT.
    Ann Rheum Dis; 2010 Feb 15; 69(2):325-31. PubMed ID: 19773290
    [Abstract] [Full Text] [Related]

  • 20. Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.
    Abadie EC, Devogealer JP, Ringe JD, Ethgen DJ, Bouvenot GM, Kreutz G, Laslop A, Orloff JJ, Vanderauwera PM, Delmas PD, Dere WH, Branco J, Altman RD, Avouac BP, Menkes CJ, Vanhaelst L, Mitlak BH, Tsouderos Y, Reginster JY.
    Semin Arthritis Rheum; 2005 Aug 15; 35(1):1-4. PubMed ID: 16084217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.